Cargando…
Clinical features of drug-induced Parkinsonism
Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several facto...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322048/ https://www.ncbi.nlm.nih.gov/pubmed/30687468 http://dx.doi.org/10.4081/ni.2018.7877 |
_version_ | 1783385547418370048 |
---|---|
author | Shiraiwa, Nobuko Tamaoka, Akira Ohkoshi, Norio |
author_facet | Shiraiwa, Nobuko Tamaoka, Akira Ohkoshi, Norio |
author_sort | Shiraiwa, Nobuko |
collection | PubMed |
description | Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson’s disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs. |
format | Online Article Text |
id | pubmed-6322048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-63220482019-01-25 Clinical features of drug-induced Parkinsonism Shiraiwa, Nobuko Tamaoka, Akira Ohkoshi, Norio Neurol Int Article Drug-induced Parkinsonism is often reversible after withdrawal of the causative drug. Its clinical course, however, is not well understood, as the majority of cases are caused by drugs prescribed by departments outside of neurology. We reviewed 21 cases of drug-induced parkinsonism for several factors, including age, sex, causative drug and reason for prescription, department by which it was prescribed, and outcome. The age at onset ranged from 40 to 87 years, with an average Hoehn and Yahr Scale score of 4, indicating severe disability. Sulpiride was the most commonly observed causative drug (71.4%). All causative drugs were prescribed in non-neurological departments and over one half were prescribed in non-psychiatric departments; most were prescribed to treat depression or abdominal discomfort. Ten patients (48%) were previously diagnosed with a neuromuscular disease, including cerebrovascular diseases and Parkinson’s disease. Recovery was observed in 15 cases (71%) after withdrawal of the causative drug, but lingering symptoms were observed in the remaining cases. It is suggested that physicians should be more cautious of Parkinsonian side effects when prescribing such drugs. PAGEPress Publications, Pavia, Italy 2018-12-20 /pmc/articles/PMC6322048/ /pubmed/30687468 http://dx.doi.org/10.4081/ni.2018.7877 Text en ©Copyright N. Shiraiwa et al., 2018 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0). |
spellingShingle | Article Shiraiwa, Nobuko Tamaoka, Akira Ohkoshi, Norio Clinical features of drug-induced Parkinsonism |
title | Clinical features of drug-induced Parkinsonism |
title_full | Clinical features of drug-induced Parkinsonism |
title_fullStr | Clinical features of drug-induced Parkinsonism |
title_full_unstemmed | Clinical features of drug-induced Parkinsonism |
title_short | Clinical features of drug-induced Parkinsonism |
title_sort | clinical features of drug-induced parkinsonism |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322048/ https://www.ncbi.nlm.nih.gov/pubmed/30687468 http://dx.doi.org/10.4081/ni.2018.7877 |
work_keys_str_mv | AT shiraiwanobuko clinicalfeaturesofdruginducedparkinsonism AT tamaokaakira clinicalfeaturesofdruginducedparkinsonism AT ohkoshinorio clinicalfeaturesofdruginducedparkinsonism |